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Summary  Healthcare  associated  infections  (HAI)  are  among  the  major  compli-
cations  of  modern  medical  therapy.  The  most  important  HAIs  are  those  related  to
invasive  devices:  central  line-associated  bloodstream  infections  (CLABSI),  catheter-
associated  urinary  tract  infections  (CAUTI),  ventilator-associated  pneumonia  (VAP)
as  well  as  surgical  site  infections  (SSI).  HAIs  are  associated  with  signiﬁcant  mortality,
morbidities  and  increasing  healthcare  cost.  The  cited  case-fatality  rate  ranges  from
2.3%  to  14.4%  depending  on  the  type  of  infection.  In  this  mini-review,  we  shed  light
on  these  aspects  as  well  as  drivers  to  decrease  HAIs.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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ealthcare  associated  infections  (HAI)  are  among
he major  complications  of  modern  medical
herapy due  to  the  increasing  age  and  com-
lexity of  patients,  increased  utilization  of
nvasive devices  and  often  inappropriate  use  of
ntimicrobial  therapy.  The  most  important  HAIs
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ine-associated  bloodstream  infections  (CLABSI),
atheter-associated  urinary  tract  infections
CAUTI), ventilator-associated  pneumonia  (VAP)
s well  as  surgical  site  infections  (SSI).  Many  of
hese device  associated  infections  and  SSI  are
aused by  multi-drug  resistant  organisms  (MDRO)
uch as  Clostridium  difﬁcile,  methicillin-resistant
taphylococcus  aureus  (MRSA),  vancomycin-
esistant Enterococci  (VRE)  and  multi-resistant
ram-negative  bacilli.  While  outbreaks  often
apture  the  attention  of  the  media  and  the  public,
ndemic  HAI  represent  the  majority  of  infections
ncountered in  healthcare  and  are  associated  with
nces. Published by Elsevier Ltd. All rights reserved.
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signiﬁcant  morbidity,  mortality  and  healthcare
costs [1].
There are  multiple  factors  contributing  to
HAI and  include  healthcare  associated  factors,
environmental  factors,  and  patient-related  fac-
tors. Healthcare  related  factors  include  the  use
of invasive  devices,  surgical  procedures,  and
selection pressure  from  excessive  antibiotic  use.
Environmental  factors  include  contaminated  air-
conditioning  systems  and  the  physical  layout  of  the
facility (e.g.,  open  units  with  beds  close  together).
These factors  interact  in  any  given  healthcare  sys-
tem and  multiple  factors  may  play  a  role  such
as stafﬁng  (e.g.,  nurse-to-patient  ratio)  and  the
lack of  effective  intervention  programs  designed  to
reduce HAI.  Patient-related  factors  include;  sever-
ity of  underlying  illness,  use  of  immunosuppressive
agents,  and  prolonged  hospital  stays.
Mortality and morbidity
Hospital  acquired  infections  are  associated  with  sig-
niﬁcant mortality  and  morbidities.  These  have  been
quantiﬁed  in  a  number  of  studies  although  the  mor-
tality impact  is  likely  to  be  affected  by  the  case
mix. In  a  study  from  the  USA,  case  fatality  rates  of
CLABSI were  12.3%,  VAP  14.4%,  CAUTI  2.3%,  and  SSI
2.8% [2].  In  a  study  in  a  surgical  intensive  care  unit,
the attributable  mortality  to  CLABSI  was  35%  [3].
It was  argued  that  for  most  HAIs  additional  studies
are needed  to  determine  the  attributable  mortality
as it  is difﬁcult  to  attribute  death  in  such  patients
to infection  only  in  patients  with  multiple  cofactors
in intensive  care  units  [4]. Of  all  HAIs,  CLABSI  and
VAP are  associated  with  the  highest  number  of  pre-
ventable  deaths  [6].  The  calculated  estimates  of
lives saved  in  the  United  States  by  reduction  in  the
number  of  cases  of  CLABSI  are  5520—20,239  lives,
and for  VAP  13,667—19,782  lives  [4].
Costs
HAIs  are  associated  with  substantial  cost  and  bur-
den on  healthcare  organizations  [2,5].  In  the  United
States, it  is  estimated  that  HAIs  occur  in  about
two million  patients  a  year  with  a  total  number
of deaths  of  99,000,  and  cost  of  $33  billion  each
year  [2,5].  The  SENIC  (Study  for  Efﬁcacy  of  Noso-
comial  Infection  Control)  study  estimated  the  cost
of HAIs  to  be  $4.5  billion  in  1992,  which  reached
to almost  $6.6  billion  in  2007  after  adjusting  for
inﬂation [2].  The  economic  impact  of  HAIs  in  low-
and middle-income  countries  is  poorly  studied.  In  a
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tudy  from  Mexico  City  ICUs,  CLABSI  was  associated
ith a mean  extra  hospital  cost  of  US$  11,591,  and
n attributable  extra  mortality  of  20%  [6]. A  system-
tic review  is  beyond  the  scope  of  this  commentary
ut Stone  et  al.  have  recently  reviewed  the  subject
7].
he relation between HAI rates and the
ountry’s socioeconomic level
he  country’s  economic  level  is  generally  clas-
iﬁed as  low  income,  mid  low  income  and  high
ncome. The  relation  between  HAI  rates  and  the
ocioeconomic  level  was  recently  analyzed  and
ublished  [7,8]  and  showed  that  a  higher  country
ocio-economic  level  was  correlated  with  a  lower
nfection  risk  [7,8]. The  device  utilization  rate  in
he developing  countries’  ICUs  was  similar  to  that
eported  in  US  ICUs  but  the  pooled  rate  of  CLABSI
nd VAP  in  the  International  Nosocomial  Infection
ontrol Consortium  (INICC)  system  was  higher  than
he reported  rate  in  comparable  US  ICUs  [8]. Studies
rom Europe  also  shed  light  on  the  prevalence  and
ncidence  of  HAIs  in  ICUs.  For  example  in  one  study,
0.6%  of  patients  had  ICU-acquired  infection  includ-
ng: pneumonia  (46.9%),  lower  respiratory  tract
nfection  (17.8%),  urinary  tract  infection  (17.6%),
nd bloodstream  infection  (12%)  [9].  Of  a  total  of
360 patients  with  HAIs  in  Europe,  the  commonest
ypes of  HAIs  were  respiratory  tract  infections
22.8%), urinary  tract  infections  (UTI)  (17.2%),  and
urgical site  infections  (SSI)  (15.7%)  [10]. In  Africa,
he overall  prevalence  of  HAI  range  was  2.5—14.8%
11], and  was  twice  the  average  rate  from  European
revalence as  reported  by  the  European  Center  for
isease Prevention  and  Control  [12].
Benchmarking  is  being  established  in  many
egions and  was  established  in  the  United  King-
om in  the  1990s  [13].  The  Nosocomial  Infection
ational Surveillance  Scheme  (NINSS)  in  United
ingdom is  run  by  the  Health  Protection  Agency
HPA) and  is  based  on  US  NNIS  system  [14].
imilarly, the  Krankenhaus-Infektions-Surveillance-
ystem  (KISS)  is  a German  HAI  surveillance  system
hat was  established  in  1997  [15]. For  decades,  the
DC was  the  only  source  available  to  provide  a
asis for  comparison  of  infection  rates  with  hos-
itals worldwide.  Comparing  US  CDC’s  hospitals’
ates with  those  of  hospitals  from  Western  Europe
nd Oceania  is considered  valid,  due  to  their  sim-
lar socioeconomic  conditions.  The  comparison  of
etween CDC’s  rates  and  hospitals  with  limited
esources or  with  limited  experience  in  the  ﬁeld
f infection  control—–is  difﬁcult.  The  US  hospitals
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njoy  more  than  50-year  unrivaled  experience  in
nfection control  and  surveillance,  sufﬁcient  human
nd medical  supply  resource  availability,  and  a
omprehensive  legal  framework  backing  infection
ontrol programs  and  including  mandatory  surveil-
ance and  hospital  accreditation  policies.  These
haracteristics  lead  to  signiﬁcantly  lower  HAI  rates
or CDC’s  hospitals,  and  hospitals  from  high  income
ountries,  in  contrast  to  hospitals  from  developing
conomies or  with  insufﬁcient  resources  and  expe-
ience in  infection  control.  The  chosen  benchmark
hould have  similar  data  collection  and  presenta-
ion methods  [16]. It  is  important  also  to  take  into
onsideration  any  differences  in  surveillance  envi-
onments  including  regulations  [16].
trategies for reduction of HAI
or  more  than  30  years,  it  has  been  recognized
hat many  of  these  infections  are  partially  pre-
entable and  healthcare  can  be  made  safer.  Two
road approaches  have  been  used  to  work  toward
he reduction  of  device-associated  infections  (DAI).
he ﬁrst  is  a  passive  strategy  in  which  surveillance
rotocols lead  to  reduction  in  infections  through
rompt and  timely  feedback  [17].  The  classic  study
emonstrating  the  importance  of  this  was  the  SENIC
tudy [18],  funded  by  the  United  States  Centers  for
isease Control  and  Prevention  (CDC)  and  included
38 hospitals  randomly  selected  and  stratiﬁed  by
eography,  inpatient  bed  capacity,  and  teaching
tatus [18].  The  study  showed  that  infection  control
rograms  with  dedicated  hospital  epidemiologists
nd surveillance  programs  reduced  nosocomial
nfections by  32%  compared  to  settings  without
nfection control  programs  [18].  In  their  recommen-
ations, the  Society  for  Healthcare  Epidemiology
n America  (SHEA)  Consensus  Panel  on  essential
ctivities of  Infection  Prevention  and  Control  (IPC)
rograms  in  hospitals  considered  surveillance  activ-
ties of  HAI  to  be  a  Category  I  recommendation
19].  These  recommendations  suggest  that  surveil-
ance should  include:  standardized  deﬁnitions  of
umerators  and  denominators,  identiﬁcation  and
escription  of  data  sources  and  data  collection
ersonnel and  selection  of  appropriate  methods
f measurement  [19]. While  surveillance  provides
mportant baseline  data,  in  recent  years,  more
ctive intervention  protocols  have  been  introduced
o further  reduce  the  incidence  of  HAI.  Recently  the
se of  the  bundle  concept  has  focused  attention  on
he reduction  of  DAI  in  particular.  After  successful
rials in  a  wide  variety  of  settings  [20],  a  multimodal
pproach for  the  prevention  of  HAI  has  emerged
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lobally.  In  this  multimodal  approach  for  example,
or the  reduction  of  CLABSI,  different  strategies
re included  such  as  education  and  training,  stan-
ardized  processes,  use  of  maximal  sterile  barrier
recautions,  use  of  chlorhexidine  in  alcohol  for  skin
reparation,  hand  hygiene  and  catheter  care  [21].
he beneﬁt  of  the  use  of  combined  measures  (multi-
odal  approach)  has  been  documented  on  the  rate
f vascular-access  infections  more  than  15  years
go [22].  This  study  employed  catheter-care  tech-
iques that  included  maximal  aseptic  precautions,
se of  sterile  gloves,  gown  and  drapes  and  a con-
inuing education  program  and  regular  feed-back
f the  rates  of  CLABSI  to  the  involved  staff  [22].  A
and mark  study,  the  Pronovost  study,  showed  that
 similar  evidence-based  intervention  resulted  in
p to  66%  reduction  in  rates  of  catheter-related
loodstream  infection  and  was  maintained  over  an
8-month period  [23]. This  was  further  sustained
ith reductions  in  catheter  related  bloodstream
nfections for  up  to  36  months  [24].
In 2008,  the  Society  for  Healthcare  Epidemiol-
gy of  America  (SHEA)  and  the  Infectious  Diseases
ociety  of  America  (IDSA)  and  partner  organizations
ublished a compendium  of  strategies  to  prevent
AIs in  acute  care  hospitals  [25]. The  compendium
s an  evidence-based  practical  guide  for  the  pre-
ention  of  common  HAIs  including  CAUTI,  SSI  and
LABSI.
While there  is  an  increasing  body  of  evidence
or various  evidence-based  interventions  to  reduce
AIs, they  continue  to  be  a problem  and  multi-drug
esistant organisms  (MDRO)  rates  continue  to  rise.
he problem  has  been  in  getting  healthcare  organi-
ations to  adopt  or  adapt  the  best  interventions  in
eduction  of  HAI  in  their  routine  practice.  Changing
he behavior  of  the  individual  healthcare  worker
s challenging  as  well  as  changing  the  culture  of
ny given  healthcare  organization.  It  was  estimated
hat despite  widespread  incontrovertible  evidence,
dapting  healthy  life  styles  to  quit  smoking  took  50
ears to  decrease  smoking  rates  from  80%  to 36%  in
en 35—59  years  of  age  and  to  21%  in  men  more
han 60  years  of  age  [26].  We  hope  that  culture
hange in  HAI  prevention  will  not  take  that  long!
ow can we reduce HAI?
everal  initiatives  have  been  started  to  try  to  imple-
ent evidence  based  interventions  to  reduce  HAIs.
or example,  the  QUEST  performance  improvement
rogram is  a collaborative  sponsored  by  Premier
ith technical  assistance  provided  by  the  Insti-
ute for  Healthcare  Improvement  (IHI)  [27]. This
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project  developed  strategies  in  key  areas  such  as
CLABSI, VAP,  SSI  and  CAUTI.  They  are  designed  to
‘‘hardwire’’  best  practices  into  healthcare  systems
such as  reminders  and  automatic  stop  orders  to
reduce  device  usage.  Changing  the  culture  of  an
organization  so  that  everyone  can  speak  up  if  they
detect unsafe  practices  is  another  way  forward.  In
this new  culture,  organizations  implement  train-
ing programs  and  encourage  communication  and
teamwork  to  empower  staff  with  a  focus  on  reduc-
ing preventable  infections.  Establishing  local  and
national targets  for  improvement  is  another  key  to
success. The  U.S.  Department  of  Health  &  Human
Services had  put  nine  national  targets  for  elimina-
tion of  HAI  and  monitors  the  progress  overtime  [28].
There are  some  concerns  that  highly  publicized  and
visible targets  may  occasionally  be  counterproduc-
tive as  administrators  try  to  ‘‘game’’  the  system  by
stretching deﬁnitions  in  order  to  meet  targets.
What are the drivers to prevent HAI?
Despite  strong  public  support  and  institutional  pres-
sure, the  adherence  to  evidence-based  infection
control measures  was  estimated  to  be  around  60%
[29].  The  drivers  for  reduction  of  HAI  are  multiple
and include:  pressure  from  patients,  regulation  by
the health  authorities;  fear  of  legal  action;  ﬁnancial
assistance;  and  convincing  guidelines  [30]. In  USA,
public reporting  of  HAIs  has  attracted  signiﬁcant
attention in  the  past  few  years.  The  CDC  has  put
guidelines  on  public  reporting  of  HAIs  to  try  to  alle-
viate some  of  the  problems  caused  by  ‘‘gaming’’
the system  or  undue  pressure  on  infection  preven-
tionists while  still  trying  to  achieve  accountability
and safer  patient  care  [31]. The  authors  call  for
clear deﬁnition  of  the  goals,  objectives,  and  pri-
orities of  a  public  reporting  system.  They  also
strongly recommend  that  the  outcomes  should  be
meaningfully  and  clearly  measurable  [31]. Process
measures  are  more  easily  adhered  to  and  might  be
less ambiguous  than  outcome  measures  [31].  The
same group  evaluated  10  studies,  to  assess  the  evi-
dence for  the  effectiveness  for  public  reporting  to
improve  health  care  and  found  in  conclusive  results.
No studies  speciﬁcally  investigated  reduction  of  HAI
as an  outcome  [32]. In addition,  the  lack  of  vali-
dated  risk  adjustment  methods  is  a  major  concern
for public  reporting  as  consumers  and  regulators  are
likely to  use  public  reporting  to  benchmark  hospi-
tals [33].  Cost  of  HAIs  is  another  major  driver  for
the reduction  of  these  infections.  In  the  United
States, HAIs  were  found  to  be  major  contributors
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o  hospital  readmission  [34]. Others  have  also  found
igniﬁcantly  increased  costs  associated  with  HAIs.
The Institute  for  Healthcare  Improvement  cites
ultiple  infection  control  activities  such  as:  appro-
riate precautions,  identiﬁcation  of  colonization
ith active  surveillance,  cleaning  of  environment
nd equipment,  hand  hygiene,  bundle  use,  and
ppropriate  antimicrobial  selection  [35]  as  the
rivers to  reducing  HAIs.  The  evidence  for  some  of
hese is  stronger  than  for  others  and  this  has  been
ne of  the  challenges  to  amass  a  strong  evidence
ased database  for  many  infection  control  recom-
endations.  Recent  high  quality  studies  [36,37]
ave  provided  interesting  insights  into  the  relative
oles of  the  different  components  of  the  infection
ontrol bundles.  Some  work  has  been  done  in  the
eveloping  world  and  outside  North  America  using
he bundle  concept  or  multi-modal  approaches  to
educe HAI  [38—41]. Hopefully  more  of  these  stud-
es will  be  done  outside  of  North  America  to  provide
ata which  can  be  generalized  globally.
One  controversial  aspect  of  the  modern  infec-
ion prevention  movement  is  the  call  to  adopt  zero
olerance  of  HAI  [42]. While  everyone  accepts  that
AIs should  not  occur,  there  is  a lively  debate  on
hether  ALL  HAIs  are  truly  preventable.  Thus  while
educing  HAIs  is  an  important  goal,  it  is  important
rimarily to  reduce  harm  to  patients  instead  of
eing ﬁxated  on  numbers.  The  two  are  not  mutually
xclusive  but  an  unrelenting  focus  on  ‘‘Getting  to
ero’’ driven  by  the  media  and  regulators  can  lead
o demoralization  of  the  infection  control  teams
nd a paradoxical  worsening  of  the  patient  safety
limate [42].
Barriers  to  successful  implementation  of  HAI  pre-
ention programs  are  widespread  and  vary  with  the
ifferent settings.  These  can  include  resource  lim-
tations which  have  been  well  documented  by  the
NICC group  [43], institutional  culture  (‘‘we  have
lways done  it  this  way’’)  and  sometimes  a  lack
f support  from  senior  leadership.  Often,  there  is
lso a paucity  of  high  grade  clinical  evidence  which
ome  clinicians  need  to  alter  their  clinical  practice
nd it is  difﬁcult  to  amass  this  evidence  base.
With increasingly  educated  populations  and  the
idespread  dissemination  of  information  via  social
edia, there  is  a window  of  opportunity  for  good
cience to  drive  community  and  patient  centered
pproaches to  reducing  HAIs  and  protecting  patient
afety. It  is  somewhat  ironic  that  the  most  effective
easure to  reduce  infections  had  evidence  gen-
rated  a  century  and  a half  ago  and  still  is  not
niversally practiced.  It  is  without  doubt  that  hand
ygiene is  the  cornerstone  of  any  infection  control
easures  to  reduce  HAI  [38,44]. The  renewed  inter-
st in  Semmelweiss  and  his  seminal  intervention
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